Both in Pharmaceuticals
Opus Genetics vs Enanta Pharmaceuticals
Over the past year IRD returned +59.6% and ENTA returned −2.3%; their daily moves had a correlation of 0.18.
IRD +59.6% ENTA −2.3%Growth of $1, one year, split-adjusted
| Metric | IRD | ENTA |
|---|---|---|
| Price | $3.67 | $10.71 |
| Market cap | $305.3M | $311.9M |
| Today | +0.55% | −3.95% |
| 1 month | −18.6% | −16.6% |
| 6 months | −28.6% | −25.4% |
| Year to date | +82.6% | −32.1% |
| 1 year | +85.4% | +0.8% |
| Revenue growth (YoY) | −73.8% | −21.6% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1072.6% | −135.8% |
| P/E (TTM) | — | — |
| Price / sales | 31.0× | 4.8× |
| Net cash | $53.9M | $189.5M |
| Dividend yield | — | — |
| Volatility (60d) | 91.9% | 45.8% |
| Short % of float | 21.4% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).